 Connection
Evgenia Dobrinskikh to Disease Progression
This is a "connection" page, showing publications Evgenia Dobrinskikh has written about Disease Progression.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.054 |
|
|
|
-
Ziogas IA, Conover KR, Dobrinskikh E, Al-Juboori SI, Gromer KD, Malladi P, Wright CJ, Sokol RJ, Andrews T, Taylor SA. Spatial transcriptomics supports a role for SOX4-driven signaling throughout the disease course of biliary atresia. Hepatol Commun. 2026 Aug 01; 10(8).
Score: 0.035
-
Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ, Levi J, Kopp JB, Field A, Hill A, Lucia S, Qiu L, Jiang T, Peng Y, Orlicky D, Garcia G, Herman-Edelstein M, D'Agati V, Henriksen K, Adorini L, Pruzanski M, Xie C, Krausz KW, Gonzalez FJ, Ranjit S, Dvornikov A, Gratton E, Levi M. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. J Am Soc Nephrol. 2018 01; 29(1):118-137.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|